{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:49:20Z","timestamp":1792039760341,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,15]],"date-time":"2027-10-15T00:00:00Z","timestamp":1823558400000},"content-version":"am","delay-in-days":287,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ejrad.2026.113292","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:09:03Z","timestamp":1791558543000},"page":"113292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Diagnostic performance of post-chemoradiotherapy nacVI-RADS for identifying pathological complete response in muscle-invasive bladder cancer"],"prefix":"10.1016","volume":"206","author":[{"given":"Kenichi","family":"Fukui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2738-9792","authenticated-orcid":false,"given":"Masaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2757-8083","authenticated-orcid":false,"given":"Soichiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5285-0352","authenticated-orcid":false,"given":"Yuki","family":"Arita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Yamagiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8392-2227","authenticated-orcid":false,"given":"Junichi","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9454-3345","authenticated-orcid":false,"given":"Motohiro","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2950-8767","authenticated-orcid":false,"given":"Serdar","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1028-8135","authenticated-orcid":false,"given":"Merve Nur","family":"Tasdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ukihide","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2026.113292_b0005","doi-asserted-by":"crossref","unstructured":"F. Bray, M. Laversanne, H. Sung, et al., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin. 74 (2024) 229\u2013263. Doi:10.3322\/caac.21834.","DOI":"10.3322\/caac.21834"},{"key":"10.1016\/j.ejrad.2026.113292_b0010","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2026.113292_b0015","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa2408154","article-title":"Perioperative durvalumab with neoadjuvant chemotherapy in operable bladder cancer","volume":"391","author":"Powles","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2026.113292_b0020","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2312117","article-title":"Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer","volume":"390","author":"Powles","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2026.113292_b0025","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/cncr.22556","article-title":"Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI)","volume":"109","author":"Gilbert","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejrad.2026.113292_b0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.suronc.2016.05.027","article-title":"A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer","volume":"25","author":"Yang","year":"2016","journal-title":"Surg. Oncol."},{"issue":"572","key":"10.1016\/j.ejrad.2026.113292_b0035","first-page":"e21","article-title":"The impact of pathologic response to neoadjuvant chemotherapy on conditional survival among patients with muscle-invasive bladder cancer","volume":"37","author":"Waingankar","year":"2019","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.ejrad.2026.113292_b0040","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.eururo.2013.06.049","article-title":"Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis","volume":"65","author":"Petrelli","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2026.113292_b0045","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/bju.14736","article-title":"Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: Oncological and functional outcomes of 107 patients","volume":"124","author":"Kijima","year":"2019","journal-title":"BJU Int."},{"key":"10.1016\/j.ejrad.2026.113292_b0050","doi-asserted-by":"crossref","first-page":"e6972","DOI":"10.1002\/cam4.6972","article-title":"Comparative survival analysis of bladder preservation therapy versus radical cystectomy in muscle-invasive bladder cancer","volume":"13","author":"Kang","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.ejrad.2026.113292_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104137","article-title":"Bladder-sparing treatment for muscle-invasive bladder carcinoma using immune checkpoint inhibitors","volume":"191","author":"Xu","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ejrad.2026.113292_b0060","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.eururo.2020.07.016","article-title":"Clinical restaging and tumor sequencing are inaccurate indicators of response to neoadjuvant chemotherapy for muscle-invasive bladder cancer","volume":"79","author":"Becker","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2026.113292_b0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.urology.2009.06.111","article-title":"Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer","volume":"75","author":"Yoshida","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.ejrad.2026.113292_b0070","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.eururo.2019.12.016","article-title":"Multiparametric magnetic resonance imaging as a noninvasive assessment of tumor response to neoadjuvant pembrolizumab in muscle-invasive bladder cancer: Preliminary findings from the PURE-01 study","volume":"77","author":"Necchi","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2026.113292_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110587","article-title":"Quantitative multiparametric MRI as a promising tool for the assessment of early response to neoadjuvant chemotherapy in bladder cancer","volume":"157","author":"Yang","year":"2022","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2026.113292_b0080","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","article-title":"Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting and Data System)","volume":"74","author":"Panebianco","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2026.113292_b0085","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00330-020-07153-5","article-title":"Clinical utility of the vesical imaging-reporting and data system for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions","volume":"31","author":"Arita","year":"2021","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.113292_b0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.euo.2022.07.006","article-title":"Diagnostic value of the vesical imaging-reporting and data system in bladder urothelial carcinoma with variant histology","volume":"6","author":"Arita","year":"2023","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.ejrad.2026.113292_b0095","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.eururo.2024.09.013","article-title":"The role of multiparametric magnetic resonance imaging and the Vesical Imaging-Reporting and Data System (VI-RADS) in the management of patients with bladder cancer: Vision of the American College of Radiology VI-RADS steering committee","volume":"86","author":"Panebianco","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2026.113292_b0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13244-024-01884-5","article-title":"Multiparametric MRI and artificial intelligence in predicting and monitoring treatment response in bladder cancer","volume":"16","author":"Arita","year":"2025","journal-title":"Insights Imaging"},{"key":"10.1016\/j.ejrad.2026.113292_b0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41585-023-00830-2","article-title":"Clinical application of bladder MRI and the vesical imaging-reporting and data system","volume":"21","author":"Panebianco","year":"2024","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ejrad.2026.113292_b0110","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00261-021-03365-5","article-title":"Vesical Imaging-Reporting and Data System (VI-RADS) for assessment of response to systemic therapy for bladder cancer: Preliminary report","volume":"47","author":"Pecoraro","year":"2022","journal-title":"Abdom. Radiol."},{"key":"10.1016\/j.ejrad.2026.113292_b0115","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233020","article-title":"Neoadjuvant chemotherapy VI-RADS scores for assessing muscle-invasive bladder cancer response to neoadjuvant immunotherapy with multiparametric MRI","volume":"313","author":"Brembilla","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2026.113292_b0120","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1007\/s00330-024-11327-w","article-title":"Diagnostic accuracy and inter-reader agreement of the nacVI-RADS for bladder cancer treated with neoadjuvant chemotherapy: a prospective validation study","volume":"35","author":"Dehghanpour","year":"2025","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.113292_b0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.clgc.2023.10.013","article-title":"Neoadjuvant chemoradiotherapy followed by radical cystectomy for muscle-invasive bladder cancer: Analysis of efficacy and safety in 119 patients","volume":"22","author":"Fujiwara","year":"2024","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.ejrad.2026.113292_b0130","doi-asserted-by":"crossref","unstructured":"L.H. Sobin, C. Wittekind (Eds.), TNM Classification of Malignant Tumours, 6th ed., Wiley-Liss, New York, 2002.","DOI":"10.1002\/0471463752"},{"key":"10.1016\/j.ejrad.2026.113292_b0135","doi-asserted-by":"crossref","unstructured":"F.K. Mostofi, C.J. Davis, I.A. Sesterhenn, WHO Histological Typing of Urinary Bladder Tumours, Springer, Berlin, 1999.","DOI":"10.1007\/978-3-642-59871-5"},{"key":"10.1016\/j.ejrad.2026.113292_b0140","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00330-025-11966-7","article-title":"VI-RADS quality score: development and proposal of a scoring system by the American College of Radiology VI-RADS Steering Committee","volume":"36","author":"Woo","year":"2026","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.113292_b0145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jclinepi.2010.03.002","article-title":"Guidelines for reporting reliability and agreement studies (GRRAS) were proposed","volume":"64","author":"Kottner","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ejrad.2026.113292_b0150","first-page":"1096","article-title":"Urological complications after radiation therapy\u2014nothing ventured, nothing gained: a narrative review, Transl","volume":"10","author":"Chorbi\u0144ska","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejrad.2026.113292_b0155","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3390\/ijms27020565","article-title":"Urinary biomarkers for radiation cystitis: current insights and future directions","volume":"27","author":"Mahyoob","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejrad.2026.113292_b0160","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/crad.2000.0560","article-title":"The assessment of irradiated bladder carcinoma using dynamic contrast-enhanced MR imaging","volume":"56","author":"Dobson","year":"2001","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ejrad.2026.113292_b0165","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.clon.2022.04.001","article-title":"Assessing bladder radiotherapy response with quantitative diffusion-weighted magnetic resonance imaging analysis","volume":"34","author":"Hafeez","year":"2022","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.ejrad.2026.113292_b0170","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s40644-023-00632-0","article-title":"Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: Diagnostic performance and outcomes using biparametric vs. multiparametric MRI","volume":"23","author":"Woo","year":"2023","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.ejrad.2026.113292_b0175","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1148\/rg.220084","article-title":"Imaging features in the liver after stereotactic body radiation therapy","volume":"42","author":"Navin","year":"2022","journal-title":"Radiographics"},{"key":"10.1016\/j.ejrad.2026.113292_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2026.111478","article-title":"Multiparametric MRI assessment of 6-month post-treatment response following real-time adaptive stereotactic body radiotherapy for prostate cancer: correlation with post-treatment PSA kinetics","volume":"219","author":"Woo","year":"2026","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ejrad.2026.113292_b0185","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.eururo.2025.10.010","article-title":"Multiparametric magnetic resonance imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for bladder cancer diagnosis and staging: a guide for clinicians from the American College of Radiology VI-RADS steering committee","volume":"89","author":"Panebianco","year":"2026","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2026.113292_b0190","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1007\/s00261-025-05358-0","article-title":"Application of computed diffusion-weighted imaging in vesical imaging reporting and data system assessment for bladder cancer","volume":"51","author":"Zhang","year":"2026","journal-title":"Abdom. Radiol."},{"key":"10.1016\/j.ejrad.2026.113292_b0195","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/diagnostics15070801","article-title":"Predictive potential of contrast-enhanced MRI-based delta-radiomics for chemoradiation responsiveness in muscle-invasive bladder cancer","volume":"15","author":"Isemoto","year":"2025","journal-title":"Diagnostics"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26006406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26006406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:37:30Z","timestamp":1792039050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X26006406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":39,"alternative-id":["S0720048X26006406"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.113292","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic performance of post-chemoradiotherapy nacVI-RADS for identifying pathological complete response in muscle-invasive bladder cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.113292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113292"}}